Business Description
LakeShore Biopharma Co Ltd
NAICS : 541714
SIC : 2834
ISIN : KYG9845F1090
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | -2.32 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -2 | |||||
Beneish M-Score | -2.49 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.2 | |||||
3-Year EBITDA Growth Rate | -35 | |||||
3-Year EPS without NRI Growth Rate | -5.3 | |||||
3-Year FCF Growth Rate | 9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 82.74 | |||||
9-Day RSI | 70.1 | |||||
14-Day RSI | 60.5 | |||||
6-1 Month Momentum % | -59.97 | |||||
12-1 Month Momentum % | -53.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.17 | |||||
Quick Ratio | 0.9 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 1436.12 | |||||
Days Sales Outstanding | 627.4 | |||||
Days Payable | 465.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -27.3 | |||||
Shareholder Yield % | 30.19 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 80.89 | |||||
Operating Margin % | -61.47 | |||||
Net Margin % | -63.61 | |||||
FCF Margin % | -124.44 | |||||
ROE % | -29.78 | |||||
ROA % | -11.41 | |||||
ROIC % | -17.37 | |||||
ROC (Joel Greenblatt) % | -21.58 | |||||
ROCE % | -20.5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 23.02 | |||||
PS Ratio | 0.79 | |||||
PB Ratio | 0.72 | |||||
Price-to-Tangible-Book | 0.81 | |||||
EV-to-EBIT | -4.57 | |||||
EV-to-EBITDA | -4.57 | |||||
EV-to-Revenue | 2.7 | |||||
EV-to-Forward-Revenue | 1.39 | |||||
EV-to-FCF | -2.17 | |||||
Price-to-Net-Current-Asset-Value | 20 | |||||
Earnings Yield (Greenblatt) % | -21.88 | |||||
FCF Yield % | -77.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LSB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
LakeShore Biopharma Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 37.881 | ||
EPS (TTM) ($) | -2.897 | ||
Beta | 0 | ||
Volatility % | 139.93 | ||
14-Day RSI | 60.5 | ||
14-Day ATR ($) | 0.456728 | ||
20-Day SMA ($) | 2.78084 | ||
12-1 Month Momentum % | -53.63 | ||
52-Week Range ($) | 1.88 - 11.2 | ||
Shares Outstanding (Mil) | 19.08 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
LakeShore Biopharma Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
LakeShore Biopharma Co Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
LakeShore Biopharma Co Ltd Frequently Asked Questions
What is LakeShore Biopharma Co Ltd(LSB)'s stock price today?
When is next earnings date of LakeShore Biopharma Co Ltd(LSB)?
Does LakeShore Biopharma Co Ltd(LSB) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |